Clinical Trial Update: A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial comparing AL001 oral capsules to marketed lithium carbonate capsules to study brain/plasma pharmacokinetics and safety in adults with B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• AL001
• Lithium carbonate (immediate-release capsule) (Lithium carbonate)

Snippet

Sponsor: Alzamend Neuro, Inc. | Conditions: Bipolar I Disorder | Phase 1, Phase 2 | Status: RECRUITING